Julie Jordan

Julie Jordan

Chief Medical OfficeratNeurogene· In proxies 2024–2025

Pay in FY2025-40% from the year before · Neurogene stock -9.9% the same year

Julie Jordan was paid $1.5M in FY2025 (Dec), down 40%. Neurogene stock fell 9.9% that year.

Pay$100 in the stock at the end of FY23 → $106
Pay is from the Summary Compensation Table of each Neurogene proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NeurogenePublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role +92%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?